L2 Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Buy
454
+27
+6% +$15.1K 0.02% 375
2026
Q1
$240K Buy
427
+28
+7% +$18K 0.02% 355
2025
Q4
$270K Buy
399
+25
+7% +$17K 0.04% 307
2025
Q3
$239K Buy
+374
New +$227K 0.03% 323

Other funds holding IDXX

L2 Asset Management's IDXX Position: Q2 2026 in Review

L2 Asset Management increased its Idexx Laboratories (IDXX) stake by 6.3% in Q2 2026, buying an estimated $15.1K and bringing the position to 454 shares worth $239K. The position accounts for 0.02% of the portfolio, ranked #375.

L2 Asset Management first reported a position in IDXX in Q3 2025 and has held it in 4 quarters since. The position peaked at $270K in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • L2 Asset Management held 454 shares of Idexx Laboratories worth $239K as of Q2 2026.
  • L2 Asset Management bought 27 Idexx Laboratories shares in Q2 2026, an estimated $15.1K.
  • Idexx Laboratories made up 0.02% of L2 Asset Management's portfolio in Q2 2026, its #375 holding.
  • L2 Asset Management first reported a position in Idexx Laboratories in Q3 2025 and has held it in 4 quarters since.
  • L2 Asset Management's Idexx Laboratories position peaked at $270K in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on L2 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.